HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multiple endocrine neoplasia type 2.

Abstract
Multiple endocrine neoplasia type 2 (MEN2) is an autosomal-dominant cancer syndrome characterized by variable penetrance of medullary thyroid carcinoma(MTC), pheochromocytoma (PHEO), and primary hyperparathyroidism (PHPT). MEN2 consists of two clinical subtypes, MEN2A and MEN2B. Familial medullary thyroid cancer is now viewed as a phenotypic variant of MEN2A with decreased penetrance for PHEO and PHPT rather than a distinct entity. All subtypes are caused by gain-of-function mutations of the RET proto-oncogene. Genotype-phenotype correlations exist that help predict the presence of other associated endocrine neoplasms as well as the timing of thyroid cancer development. Recognition of the clinical entity in individuals and families at risk of harboring a germline RET mutation is crucial for the management and prevention of associated malignancies. Recent guidelines released by the American Thyroid Association regarding the management of MTC will be summarized in this chapter.
AuthorsMaya Lodish
JournalFrontiers of hormone research (Front Horm Res) Vol. 41 Pg. 16-29 ( 2013) ISSN: 1662-3762 [Electronic] Switzerland
PMID23652668 (Publication Type: Journal Article)
CopyrightCopyright © 2013 S. Karger AG, Basel.
Chemical References
  • Enzyme Inhibitors
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Protein-Tyrosine Kinases
  • Proto-Oncogene Proteins c-ret
Topics
  • Adrenal Gland Neoplasms (diagnosis, genetics, therapy)
  • Adrenalectomy
  • Carcinoma, Medullary (congenital, diagnosis, genetics, therapy)
  • Carcinoma, Neuroendocrine
  • Enzyme Inhibitors (therapeutic use)
  • Genetic Association Studies
  • Genetic Testing
  • Humans
  • Hyperparathyroidism, Primary (diagnosis)
  • Multiple Endocrine Neoplasia Type 2a (diagnosis, genetics, therapy)
  • Multiple Endocrine Neoplasia Type 2b (genetics)
  • Neoplasm Metastasis (diagnosis)
  • Pheochromocytoma (diagnosis, genetics, therapy)
  • Practice Guidelines as Topic
  • Protein-Tyrosine Kinases (antagonists & inhibitors)
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins c-ret (genetics)
  • Thyroid Neoplasms (diagnosis, genetics, pathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: